Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction
Condition(s):Fetal Growth RetardationLast Updated:March 20, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Fetal Growth RetardationLast Updated:March 20, 2020Completed
Condition(s):ReadingLast Updated:September 10, 2022Active, not recruiting
Condition(s):Growth Disorders; Growth Failure; Growth Hormone Treatment; GrowthLast Updated:December 13, 2023Recruiting
Condition(s):Healthy VolunteersLast Updated:April 19, 2011Completed
Condition(s):Growth Hormone DeficiencyLast Updated:July 23, 2015Completed
Condition(s):Fetal Growth RetardationLast Updated:January 25, 2023Completed
Condition(s):Growth Hormone Deficiency; Panhypopituitarism; Short StatureLast Updated:May 30, 2018Completed
Condition(s):Intrauterine Growth RestrictionLast Updated:August 18, 2021Withdrawn
Condition(s):Growth; Child Development; Disability, DevelopmentalLast Updated:June 24, 2019Completed
Condition(s):Chronic Myelogenous Leukemia; Short StatureLast Updated:July 17, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.